DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
Mangili F, Esposito E, Treppiedi D, Catalano R, Marra G, Di Muro G, Barbieri AM, Locatelli M, Lania AG, Mangone A, Spada A, Arosio M, Peverelli E, Mantovani G.
Mangili F, et al.
Front Endocrinol (Lausanne). 2022 Jun 3;13:867822. doi: 10.3389/fendo.2022.867822. eCollection 2022.
Front Endocrinol (Lausanne). 2022.
PMID: 35721701
Free PMC article.